Medicine,
Journal Year:
2024,
Volume and Issue:
103(31), P. e39134 - e39134
Published: Aug. 2, 2024
Background:
Irritable
bowel
syndrome
(IBS)
is
a
major
global
healthcare
burden
that
requires
effective
and
well-tolerated
intervention.
This
study
aimed
to
investigate
the
effectiveness
safety
of
Bacillus
coagulans
BCP92,
probiotic,
in
managing
IBS
symptoms.
Methods:
randomized
controlled
trial
included
100
participants
who
strictly
adhered
protocol.
Various
parameters
such
as
severity,
digestive
symptom
frequency,
gastrointestinal
stool
consistency,
interleukin-6
levels,
stress
relief,
anxiety
levels
were
evaluated
over
12
weeks.
Results:
B.
BCP92
significantly
improved
severity
(
P
<
.001),
frequency
.001)
compared
with
control
group.
The
consistency
.001).
Mental
relief
was
remarkable
=
differentiating
test
groups.
No
significant
change
observed;
however,
assessment
revealed
an
excellent
profile
no
reported
severe
adverse
events.
Conclusion:
one
most
promising
therapeutic
options
for
management
because
it
has
shown
efficacy
alleviating
symptoms
among
patients
suffering
from
this
condition,
resulting
changes
addition
improving
overall
mental
well-being
its
users,
thereby
foreseeing
elimination
any
potential
side
effects
experienced
during
implementation
approach
strategy
within
our
health
care
system,
patient
outcomes
leading
individualization
treatment
plans
all
individuals
diagnosed
disease
entity
may
have
symptoms,
including
abdominal
pain
or
discomfort
associated
habits.
Gut Microbes,
Journal Year:
2023,
Volume and Issue:
15(1)
Published: Feb. 7, 2023
Current
treatment
for
celiac
disease
(CD)
is
adhering
to
a
gluten-free
diet
(GFD),
although
its
long-term
molecular
effects
are
still
undescribed.
New
features
detectable
in
stool
may
improve
and
facilitate
noninvasive
clinical
management
of
CD.
For
this
purpose,
fecal
small
non-coding
RNAs
(sncRNAs)
gut
microbiome
profiles
were
concomitantly
explored
CD
subjects
relation
strict
(or
not)
GFD
adherence
over
time.
In
observational
study,
we
performed
RNA
shotgun
metagenomic
sequencing
from
63
treated
(tCD)
3
untreated
as
well
66
sex-
age-matched
healthy
controls.
tCD
included
51
individuals
on
with
negative
transglutaminase
(TG)
serology
(tCD-TG-)
12
symptomatic
not
strict/short-time
positive
TG
(tCD-TG+).
Samples
additional
40
adult
cohort
19
pediatric
sex/age
matched
controls
analyzed
further
test
the
outcomes.
Several
miRNA
microbial
altered
(adj.
p
<
.05).
Findings
validated
external
group
tCD-TG-,
duration
correlated
five
levels
(p
.05):
miR-4533-3p
miR-2681-3p,
longer
adherence,
less
expression
differed
tCD-TG+
patients
showed
similar
dysregulation.
Immune-response,
trans-membrane
transport
cell
death
pathways
enriched
targets
identified
miRNAs.
Bifidobacterium
longum,
Ruminococcus
bicirculans,
Haemophilus
parainfluenzae
abundances
shifted
.05)
progressive
reduction
denitrification
length.
Integrative
analysis
highlighted
121
miRNA-bacterial
relationships
Specific
patterns
characterize
subjects,
reflecting
either
or
inflammatory
status,
case
adherence.
Our
findings
suggest
novel
host-microbial
interplays
could
help
discovery
biomarkers
monitoring
Journal of Neurogastroenterology and Motility,
Journal Year:
2022,
Volume and Issue:
28(3), P. 357 - 375
Published: June 20, 2022
Other
SectionsAbstractIntroductionCurrent
Challenges
of
Disorders
Gut-Brain
InteractionsGastrointestinal
Cells
Dynamics
in
Gut
Health
and
InteractionsEnterochromaffin
Mediating
PhysiologyEnterochromaffin
Pathophysiology
Mechanisms
InteractionsPathophysiology-directed
Therapeutic
Approach
for
InteractionsConclusion
Further
DirectionsFinancial
supportConflicts
interestAuthor
contributionsReferences
Gut and Liver,
Journal Year:
2021,
Volume and Issue:
16(3), P. 331 - 340
Published: Nov. 18, 2021
Following
acute
gastroenteritis
(AGE)
due
to
bacteria,
viruses,
or
protozoa,
a
subset
of
patients
develop
new
onset
Rome
criteria
positive
irritable
bowel
syndrome
(IBS),
called
postinfection
IBS
(PI-IBS).
The
pooled
prevalence
PI-IBS
following
AGE
was
11.5%.
is
the
best
natural
model
that
suggests
with
may
have
an
organic
basis.
Several
factors
are
associated
greater
risk
development
including
female
sex,
younger
age,
smoking,
severity
AGE,
abdominal
pain,
bleeding
per
rectum,
treatment
antibiotics,
anxiety,
depression,
somatization,
neuroticism,
recent
adverse
life
events,
hypochondriasis,
extroversion,
negative
illness
beliefs,
history
stress,
sleep
disturbance,
and
family
functional
gastrointestinal
disorders
(FGIDs),
currently
disorder
gut-brain
interaction.
Most
present
either
diarrhea-predominant
mixed
subtype
IBS,
overlap
other
FGIDs,
such
as
dyspepsia
common.
drugs
used
treat
non-constipation
also
be
useful
in
treatment.
Since
randomized
controlled
trials
on
efficacy
rare,
more
studies
needed
this
issue.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(6), P. 1361 - 1361
Published: March 10, 2023
Most
female
patients
with
irritable
bowel
syndrome
(IBS)
complain
of
abdominal
bloating
rather
than
pain
and
diarrhea.
The
higher
incidence
in
women
could
be
due
to
the
so-called
dysfunctional
gas
handling.
Since
diet
seems
most
effective
durable
strategy
for
managing
IBS
symptoms,
we
aimed
evaluate
effects
a
12
week
based
on
relatively
new
cereal,
Tritordeum
(TBD),
gastrointestinal
(GI)
anthropometric
bioelectrical
impedance
parameters,
psychological
profiles
18
diarrhea-predominant
(IBS-D)
as
dominant
symptom.
Severity
Scoring
System
(IBS-SSS),
Symptom
Checklist-90
Revised,
Italian
version
36-Item
Short-Form
Health
Survey,
IBS-Quality
Life
questionnaire
were
administered.
TBD
reduces
IBS-SSS
"Intensity
bloating"
concomitant
improvement
profile.
No
correlation
was
found
between
"Abdominal
circumference".
Anxiety,
depression,
somatization,
interpersonal
sensitivity,
phobic
avoidance
manifestations
significantly
reduced
after
TBD.
Lastly,
anxiety
correlated
bloating".
Overall,
these
results
suggest
possibility
lowering
improving
profile
IBS-D
using
an
alternative
grain
such
Tritordeum.
Gut and Liver,
Journal Year:
2024,
Volume and Issue:
18(4), P. 578 - 592
Published: April 29, 2024
Disorders
of
the
gut-brain
interaction
(DGBIs)
are
presently
classified
into
mutually
exclusive
anatomical
area-related
symptom-based
categories
according
to
Rome
IV
criteria.
The
pathophysiology
visceral
nociception,
which
contributes
wide
range
symptoms
DGBIs,
involves
complex
psychobiological
processes
arising
from
bidirectional
interactions
multiple
systems
at
gut
and
brain
levels,
affect
symptom
expression
illness
behaviors.
attitude
toward
an
pain
bowel
habit
vary
across
cultures
with
variable
interpretation
based
on
sociocultural
beliefs,
may
not
tally
medical
definitions.
Thus,
psychological
factors
impact
DGBI
definitions,
their
severity
health
care
utilization.
Due
poor
localization
multisegment
referral
pain,
site
correspond
affected
segment,
there
be
a
degree
overlap
among
symptoms.
somewhat
restrictively
defined
criteria
assume
one-to-one
correlation
underlying
ignore
overlapping
nonstandardized
categories,
change
or
shift
in
category
over
time.
microorganic
nature
DGBIs
resulting
systemic,
metabolic
motility
disorders,
dysbiosis
inflammation
addressed
Although
is
multidimensional
clinical
profile
that
does
address
these
factors,
it
followed
rigorously
practice.
Threshold
changes
for
diagnostic
addition/deletion
leads
variation
different
uncertain
comparability
results.
excellent
research
studies
therapeutic
trials
homogenous
populations,
further
improvement
needed
wider
applicability
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(17), P. 5124 - 5124
Published: Aug. 29, 2024
Globally,
irritable
bowel
syndrome
(IBS)
is
present
in
approximately
10%
of
the
population.
While
this
condition
does
not
pose
a
risk
complications,
it
has
substantial
impact
on
patient’s
quality
life.
Moreover,
disease
significant
financial
healthcare
systems.
This
includes
direct
costs
associated
with
diagnosis
and
treatment
these
patients,
as
well
indirect
that
arise
from
work
absenteeism
reduced
productivity.
In
light
data,
recent
research
focused
elucidating
pathophysiological
basis
order
to
improve
life
for
affected
individuals.
Despite
extensive
date,
we
still
do
fully
understand
precise
mechanisms
underlying
IBS.
Numerous
studies
have
demonstrated
involvement
gut–brain
axis,
visceral
hypersensitivity,
gastrointestinal
dysmotility,
gut
microbiota
dysbiosis,
food
allergies
intolerances,
low-grade
mucosal
inflammation,
genetic
factors,
psychosocial
factors.
The
acquisition
new
data
crucial
advancement
optimal
therapeutic
approaches
aimed
at
enhancing
general
health
patients
while
simultaneously
reducing
burden
ailment.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(3), P. 567 - 567
Published: Feb. 2, 2025
Background:
Dairy
consumption
has
been
associated
with
various
health
outcomes
that
may
be
mediated
by
changes
in
gut
microbiota.
Methods:
This
cross-sectional
study
investigated
the
association
between
colonic
mucosa-associated
microbiota
and
self-reported
intake
of
total
dairy,
milk,
cheese,
yogurt.
A
97
mucosal
biopsies
collected
from
34
polyp-free
individuals
were
analyzed.
past
year
was
assessed
using
a
food
frequency
questionnaire.
The
16S
rRNA
gene
V4
region
amplified
sequenced.
Operational
taxonomic
unit
(OTU)
classification
performed
UPARSE
SILVA
databases.
OTU
diversity
relative
abundance
compared
lower
vs.
higher
dairy
groups.
Multivariable
negative
binomial
regression
models
for
panel
data
used
to
estimate
incidence
rate
ratio
95%
confidence
interval
bacterial
counts
consumption.
False
discovery
rate-adjusted
p
values
(q
value)
<
0.05
indicated
statistical
significance.
Results:
Higher
milk
cheese
alpha
microbial
(adjusted
0.05).
also
Faecalibacterium.
Akkermansia.
Bacteroides.
Conclusions:
influence
host
modulating
structure
composition
adherent
Annals of Animal Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 15, 2025
Abstract
Gut
dysbiosis
in
poultry
presents
a
major
challenge,
requiring
comprehensive
approach
to
sustain
optimal
gut
health
and
ensure
animal
welfare.
This
review
emphasizes
the
importance
of
integrated
management
practices
explores
alternatives
antibiotics,
including
probiotics,
prebiotics,
synbiotics,
postbiotics,
phytogenic
compounds,
medicinal
plants,
organic
acids.
Additionally,
it
advocates
tailored
nutritional
strategies
specific
broiler
strains
highlights
potential
advanced
biotechnologies
for
nutrition
management.
Maintaining
effective
is
essential
not
only
welfare
but
also
economic
sustainability
farming.
Given
implications
antibiotic
use
human
health,
“One
Health”
critical
recognizing
interconnection
between
animal,
human,
environmental
health.
Research
should
prioritize
understanding
host-microbiome
interactions,
developing
innovative
therapies,
enhancing
diagnostic
tools
early
detection
intervention
dysbiosis.
Addressing
this
complex
issue
requires
collaboration
among
researchers,
veterinarians,
feed
manufacturers,
producers
create
sustainable
solutions
that
improve
production
efficiency,
while
reducing
reliance
on
antibiotics.
Implementing
holistic
strategy
encompasses
various
aspects
The
industry
can
mitigate
adverse
effects
promote
overall
chickens.